Logo

Atlas Biolabs Adds Agilent Platform to Expression Profiling Services

Aug 20, 2008

NEW YORK (GenomeWeb News) – German genomics services firm Atlas Biolabs said today that it has added Agilent Technologies’ microarray platform to its expression profiling services.

The Agilent platform joins competing platforms sold by Affymetrix and Illumina as part of Atlas’ offerings. In addition to offering catalog and custom chips from the microarray manufacturers, Atlas said it provides customers with chip design in custom array formats and a detailed analysis of the expression data.

Further terms of the agreement were not disclosed.

Breaking News
The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.